Alan Lotvin
CIK 1472795 · EVP&President-PharmacyServices · last filed 2026-05-29
Alan Lotvin is an EVP&President-PharmacyServices who has filed 29 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing, for PROK, was dated May 29, 2026. Across all open-market trades the lifetime net is −$19.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.18M
3
29
-$19.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PROK | Director | — | $1.64 | — | $0 | 4 | 2026-05-29 |
| CVS | EVP&President-PharmacyServices | 109,675 | $101.96 | $11.18M | -$18.82M | 16 | 2022-08-05 |
| MAGELLAN HEALTH INC (MGLN) Delisted | President, ICore Healthcare | 1,949 | $94.99 | $185.1K | -$950.8K | 8 | 2011-05-02 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | PROK | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | PROK | Grant (A) | — | $0 | EDGAR |
| 2024-06-03 | PROK | Grant (A) | — | $0 | EDGAR |
| 2023-07-03 | PROK | Grant (A) | — | $0 | EDGAR |
| 2022-08-05 | CVS | Mixed | — | -$5.95M | EDGAR |
| 2022-07-13 | — | Grant (A) | — | $0 | |
| 2022-04-05 | CVS | Mixed | −38,129 | -$3.85M | EDGAR |
| 2022-02-23 | CVS | Grant (A) | +85,971 | $0 | EDGAR |
| 2022-02-02 | CVS | Mixed | — | -$90.6K | EDGAR |
| 2021-12-28 | CVS | Tax (F) | −200 | -$17.8K | EDGAR |